Here, we found that STAT3 was downregulated in response to treatment with MSC-exosomes, suggesting that these particles targeted STAT3 to suppress BCL2 expression and the subsequent activation of apoptosis in AML cells. The gene discussed is STAT3; the disease is acute myeloid leukemia.